<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CV9K" lang="spa" raw_text_char_length="3654" raw_text_md5="0096f08d058329c9c9cf24d367e79789" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="112" id="segment-0" start_char="1">
<ORIGINAL_TEXT>El raloxifeno podría ser un “tratamiento eficaz” en casos leves de Covid-19, según cálculos con supercomputación</ORIGINAL_TEXT>
<TOKEN end_char="2" id="token-0-0" morph="none" pos="word" start_char="1">El</TOKEN>
<TOKEN end_char="13" id="token-0-1" morph="none" pos="word" start_char="4">raloxifeno</TOKEN>
<TOKEN end_char="20" id="token-0-2" morph="none" pos="word" start_char="15">podría</TOKEN>
<TOKEN end_char="24" id="token-0-3" morph="none" pos="word" start_char="22">ser</TOKEN>
<TOKEN end_char="27" id="token-0-4" morph="none" pos="word" start_char="26">un</TOKEN>
<TOKEN end_char="29" id="token-0-5" morph="none" pos="punct" start_char="29">“</TOKEN>
<TOKEN end_char="40" id="token-0-6" morph="none" pos="word" start_char="30">tratamiento</TOKEN>
<TOKEN end_char="47" id="token-0-7" morph="none" pos="word" start_char="42">eficaz</TOKEN>
<TOKEN end_char="48" id="token-0-8" morph="none" pos="punct" start_char="48">”</TOKEN>
<TOKEN end_char="51" id="token-0-9" morph="none" pos="word" start_char="50">en</TOKEN>
<TOKEN end_char="57" id="token-0-10" morph="none" pos="word" start_char="53">casos</TOKEN>
<TOKEN end_char="63" id="token-0-11" morph="none" pos="word" start_char="59">leves</TOKEN>
<TOKEN end_char="66" id="token-0-12" morph="none" pos="word" start_char="65">de</TOKEN>
<TOKEN end_char="75" id="token-0-13" morph="none" pos="unknown" start_char="68">Covid-19</TOKEN>
<TOKEN end_char="76" id="token-0-14" morph="none" pos="punct" start_char="76">,</TOKEN>
<TOKEN end_char="82" id="token-0-15" morph="none" pos="word" start_char="78">según</TOKEN>
<TOKEN end_char="91" id="token-0-16" morph="none" pos="word" start_char="84">cálculos</TOKEN>
<TOKEN end_char="95" id="token-0-17" morph="none" pos="word" start_char="93">con</TOKEN>
<TOKEN end_char="112" id="token-0-18" morph="none" pos="word" start_char="97">supercomputación</TOKEN>
<TRANSLATED_TEXT>raloxifene could be an "effective treatment" in mild cases of Covid-19, calculated by supercomputing</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="143" id="segment-1" start_char="116">
<ORIGINAL_TEXT>Prueba virtual con moléculas</ORIGINAL_TEXT>
<TOKEN end_char="121" id="token-1-0" morph="none" pos="word" start_char="116">Prueba</TOKEN>
<TOKEN end_char="129" id="token-1-1" morph="none" pos="word" start_char="123">virtual</TOKEN>
<TOKEN end_char="133" id="token-1-2" morph="none" pos="word" start_char="131">con</TOKEN>
<TOKEN end_char="143" id="token-1-3" morph="none" pos="word" start_char="135">moléculas</TOKEN>
<TRANSLATED_TEXT>Virtual test with molecules</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="157" id="segment-2" start_char="146">
<ORIGINAL_TEXT>..Redacción.</ORIGINAL_TEXT>
<TOKEN end_char="147" id="token-2-0" morph="none" pos="punct" start_char="146">..</TOKEN>
<TOKEN end_char="156" id="token-2-1" morph="none" pos="word" start_char="148">Redacción</TOKEN>
<TOKEN end_char="157" id="token-2-2" morph="none" pos="punct" start_char="157">.</TOKEN>
<TRANSLATED_TEXT>.. writing.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="307" id="segment-3" start_char="159">
<ORIGINAL_TEXT>Raloxifeno, un medicamento génerico para la osteoporosis que previene la pérdida ósea en mujeres en la postmenopausia, se perfila como un fármaco que</ORIGINAL_TEXT>
<TOKEN end_char="168" id="token-3-0" morph="none" pos="word" start_char="159">Raloxifeno</TOKEN>
<TOKEN end_char="169" id="token-3-1" morph="none" pos="punct" start_char="169">,</TOKEN>
<TOKEN end_char="172" id="token-3-2" morph="none" pos="word" start_char="171">un</TOKEN>
<TOKEN end_char="184" id="token-3-3" morph="none" pos="word" start_char="174">medicamento</TOKEN>
<TOKEN end_char="193" id="token-3-4" morph="none" pos="word" start_char="186">génerico</TOKEN>
<TOKEN end_char="198" id="token-3-5" morph="none" pos="word" start_char="195">para</TOKEN>
<TOKEN end_char="201" id="token-3-6" morph="none" pos="word" start_char="200">la</TOKEN>
<TOKEN end_char="214" id="token-3-7" morph="none" pos="word" start_char="203">osteoporosis</TOKEN>
<TOKEN end_char="218" id="token-3-8" morph="none" pos="word" start_char="216">que</TOKEN>
<TOKEN end_char="227" id="token-3-9" morph="none" pos="word" start_char="220">previene</TOKEN>
<TOKEN end_char="230" id="token-3-10" morph="none" pos="word" start_char="229">la</TOKEN>
<TOKEN end_char="238" id="token-3-11" morph="none" pos="word" start_char="232">pérdida</TOKEN>
<TOKEN end_char="243" id="token-3-12" morph="none" pos="word" start_char="240">ósea</TOKEN>
<TOKEN end_char="246" id="token-3-13" morph="none" pos="word" start_char="245">en</TOKEN>
<TOKEN end_char="254" id="token-3-14" morph="none" pos="word" start_char="248">mujeres</TOKEN>
<TOKEN end_char="257" id="token-3-15" morph="none" pos="word" start_char="256">en</TOKEN>
<TOKEN end_char="260" id="token-3-16" morph="none" pos="word" start_char="259">la</TOKEN>
<TOKEN end_char="275" id="token-3-17" morph="none" pos="word" start_char="262">postmenopausia</TOKEN>
<TOKEN end_char="276" id="token-3-18" morph="none" pos="punct" start_char="276">,</TOKEN>
<TOKEN end_char="279" id="token-3-19" morph="none" pos="word" start_char="278">se</TOKEN>
<TOKEN end_char="287" id="token-3-20" morph="none" pos="word" start_char="281">perfila</TOKEN>
<TOKEN end_char="292" id="token-3-21" morph="none" pos="word" start_char="289">como</TOKEN>
<TOKEN end_char="295" id="token-3-22" morph="none" pos="word" start_char="294">un</TOKEN>
<TOKEN end_char="303" id="token-3-23" morph="none" pos="word" start_char="297">fármaco</TOKEN>
<TOKEN end_char="307" id="token-3-24" morph="none" pos="word" start_char="305">que</TOKEN>
<TRANSLATED_TEXT>Raloxifene, a gene drug for osteoporosis that prevents bone loss in postmenopausal women, is outlined as a drug that</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="328" id="segment-4" start_char="310">
<ORIGINAL_TEXT>"podría ser eficaz"</ORIGINAL_TEXT>
<TOKEN end_char="310" id="token-4-0" morph="none" pos="punct" start_char="310">"</TOKEN>
<TOKEN end_char="316" id="token-4-1" morph="none" pos="word" start_char="311">podría</TOKEN>
<TOKEN end_char="320" id="token-4-2" morph="none" pos="word" start_char="318">ser</TOKEN>
<TOKEN end_char="327" id="token-4-3" morph="none" pos="word" start_char="322">eficaz</TOKEN>
<TOKEN end_char="328" id="token-4-4" morph="none" pos="punct" start_char="328">"</TOKEN>
<TRANSLATED_TEXT>could be effective</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="400" id="segment-5" start_char="331">
<ORIGINAL_TEXT>para los pacientes con Covid-19 que presentan una sintomatología leve.</ORIGINAL_TEXT>
<TOKEN end_char="334" id="token-5-0" morph="none" pos="word" start_char="331">para</TOKEN>
<TOKEN end_char="338" id="token-5-1" morph="none" pos="word" start_char="336">los</TOKEN>
<TOKEN end_char="348" id="token-5-2" morph="none" pos="word" start_char="340">pacientes</TOKEN>
<TOKEN end_char="352" id="token-5-3" morph="none" pos="word" start_char="350">con</TOKEN>
<TOKEN end_char="361" id="token-5-4" morph="none" pos="unknown" start_char="354">Covid-19</TOKEN>
<TOKEN end_char="365" id="token-5-5" morph="none" pos="word" start_char="363">que</TOKEN>
<TOKEN end_char="375" id="token-5-6" morph="none" pos="word" start_char="367">presentan</TOKEN>
<TOKEN end_char="379" id="token-5-7" morph="none" pos="word" start_char="377">una</TOKEN>
<TOKEN end_char="394" id="token-5-8" morph="none" pos="word" start_char="381">sintomatología</TOKEN>
<TOKEN end_char="399" id="token-5-9" morph="none" pos="word" start_char="396">leve</TOKEN>
<TOKEN end_char="400" id="token-5-10" morph="none" pos="punct" start_char="400">.</TOKEN>
<TRANSLATED_TEXT>for patients with Covid-19 with mild symptomatology.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="529" id="segment-6" start_char="402">
<ORIGINAL_TEXT>En pruebas realizadas mediante simulación computacional ha demostrado eficacia evitando la replicación del virus en las células.</ORIGINAL_TEXT>
<TOKEN end_char="403" id="token-6-0" morph="none" pos="word" start_char="402">En</TOKEN>
<TOKEN end_char="411" id="token-6-1" morph="none" pos="word" start_char="405">pruebas</TOKEN>
<TOKEN end_char="422" id="token-6-2" morph="none" pos="word" start_char="413">realizadas</TOKEN>
<TOKEN end_char="431" id="token-6-3" morph="none" pos="word" start_char="424">mediante</TOKEN>
<TOKEN end_char="442" id="token-6-4" morph="none" pos="word" start_char="433">simulación</TOKEN>
<TOKEN end_char="456" id="token-6-5" morph="none" pos="word" start_char="444">computacional</TOKEN>
<TOKEN end_char="459" id="token-6-6" morph="none" pos="word" start_char="458">ha</TOKEN>
<TOKEN end_char="470" id="token-6-7" morph="none" pos="word" start_char="461">demostrado</TOKEN>
<TOKEN end_char="479" id="token-6-8" morph="none" pos="word" start_char="472">eficacia</TOKEN>
<TOKEN end_char="488" id="token-6-9" morph="none" pos="word" start_char="481">evitando</TOKEN>
<TOKEN end_char="491" id="token-6-10" morph="none" pos="word" start_char="490">la</TOKEN>
<TOKEN end_char="503" id="token-6-11" morph="none" pos="word" start_char="493">replicación</TOKEN>
<TOKEN end_char="507" id="token-6-12" morph="none" pos="word" start_char="505">del</TOKEN>
<TOKEN end_char="513" id="token-6-13" morph="none" pos="word" start_char="509">virus</TOKEN>
<TOKEN end_char="516" id="token-6-14" morph="none" pos="word" start_char="515">en</TOKEN>
<TOKEN end_char="520" id="token-6-15" morph="none" pos="word" start_char="518">las</TOKEN>
<TOKEN end_char="528" id="token-6-16" morph="none" pos="word" start_char="522">células</TOKEN>
<TOKEN end_char="529" id="token-6-17" morph="none" pos="punct" start_char="529">.</TOKEN>
<TRANSLATED_TEXT>In computer simulation testing, it has been shown to be effective in preventing virus replication in cells.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="714" id="segment-7" start_char="533">
<ORIGINAL_TEXT>Pruebas realizadas mediante supercomputación han demostrado que el raloxifeno es eficaz evitando la replicación del virus en las células y con ello, evita la propagación del Covid-19</ORIGINAL_TEXT>
<TOKEN end_char="539" id="token-7-0" morph="none" pos="word" start_char="533">Pruebas</TOKEN>
<TOKEN end_char="550" id="token-7-1" morph="none" pos="word" start_char="541">realizadas</TOKEN>
<TOKEN end_char="559" id="token-7-2" morph="none" pos="word" start_char="552">mediante</TOKEN>
<TOKEN end_char="576" id="token-7-3" morph="none" pos="word" start_char="561">supercomputación</TOKEN>
<TOKEN end_char="580" id="token-7-4" morph="none" pos="word" start_char="578">han</TOKEN>
<TOKEN end_char="591" id="token-7-5" morph="none" pos="word" start_char="582">demostrado</TOKEN>
<TOKEN end_char="595" id="token-7-6" morph="none" pos="word" start_char="593">que</TOKEN>
<TOKEN end_char="598" id="token-7-7" morph="none" pos="word" start_char="597">el</TOKEN>
<TOKEN end_char="609" id="token-7-8" morph="none" pos="word" start_char="600">raloxifeno</TOKEN>
<TOKEN end_char="612" id="token-7-9" morph="none" pos="word" start_char="611">es</TOKEN>
<TOKEN end_char="619" id="token-7-10" morph="none" pos="word" start_char="614">eficaz</TOKEN>
<TOKEN end_char="628" id="token-7-11" morph="none" pos="word" start_char="621">evitando</TOKEN>
<TOKEN end_char="631" id="token-7-12" morph="none" pos="word" start_char="630">la</TOKEN>
<TOKEN end_char="643" id="token-7-13" morph="none" pos="word" start_char="633">replicación</TOKEN>
<TOKEN end_char="647" id="token-7-14" morph="none" pos="word" start_char="645">del</TOKEN>
<TOKEN end_char="653" id="token-7-15" morph="none" pos="word" start_char="649">virus</TOKEN>
<TOKEN end_char="656" id="token-7-16" morph="none" pos="word" start_char="655">en</TOKEN>
<TOKEN end_char="660" id="token-7-17" morph="none" pos="word" start_char="658">las</TOKEN>
<TOKEN end_char="668" id="token-7-18" morph="none" pos="word" start_char="662">células</TOKEN>
<TOKEN end_char="670" id="token-7-19" morph="none" pos="word" start_char="670">y</TOKEN>
<TOKEN end_char="674" id="token-7-20" morph="none" pos="word" start_char="672">con</TOKEN>
<TOKEN end_char="679" id="token-7-21" morph="none" pos="word" start_char="676">ello</TOKEN>
<TOKEN end_char="680" id="token-7-22" morph="none" pos="punct" start_char="680">,</TOKEN>
<TOKEN end_char="686" id="token-7-23" morph="none" pos="word" start_char="682">evita</TOKEN>
<TOKEN end_char="689" id="token-7-24" morph="none" pos="word" start_char="688">la</TOKEN>
<TOKEN end_char="701" id="token-7-25" morph="none" pos="word" start_char="691">propagación</TOKEN>
<TOKEN end_char="705" id="token-7-26" morph="none" pos="word" start_char="703">del</TOKEN>
<TOKEN end_char="714" id="token-7-27" morph="none" pos="unknown" start_char="707">Covid-19</TOKEN>
<TRANSLATED_TEXT>Supercomputing tests have shown that raloxifene is effective in preventing virus replication in cells and thereby preventing the spread of Covid-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="773" id="segment-8" start_char="718">
<ORIGINAL_TEXT>Así lo anunció este jueves el consorcio de investigación</ORIGINAL_TEXT>
<TOKEN end_char="720" id="token-8-0" morph="none" pos="word" start_char="718">Así</TOKEN>
<TOKEN end_char="723" id="token-8-1" morph="none" pos="word" start_char="722">lo</TOKEN>
<TOKEN end_char="731" id="token-8-2" morph="none" pos="word" start_char="725">anunció</TOKEN>
<TOKEN end_char="736" id="token-8-3" morph="none" pos="word" start_char="733">este</TOKEN>
<TOKEN end_char="743" id="token-8-4" morph="none" pos="word" start_char="738">jueves</TOKEN>
<TOKEN end_char="746" id="token-8-5" morph="none" pos="word" start_char="745">el</TOKEN>
<TOKEN end_char="756" id="token-8-6" morph="none" pos="word" start_char="748">consorcio</TOKEN>
<TOKEN end_char="759" id="token-8-7" morph="none" pos="word" start_char="758">de</TOKEN>
<TOKEN end_char="773" id="token-8-8" morph="none" pos="word" start_char="761">investigación</TOKEN>
<TRANSLATED_TEXT>So announced this Thursday by the research consortium</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="787" id="segment-9" start_char="776">
<ORIGINAL_TEXT>Excalate4Cov</ORIGINAL_TEXT>
<TOKEN end_char="787" id="token-9-0" morph="none" pos="word" start_char="776">Excalate4Cov</TOKEN>
</SEG>
<SEG end_char="905" id="segment-10" start_char="790">
<ORIGINAL_TEXT>que utiliza una plataforma de supercomputación para estudiar el impacto de moléculas conocidas frente al SARS-CoV-2.</ORIGINAL_TEXT>
<TOKEN end_char="792" id="token-10-0" morph="none" pos="word" start_char="790">que</TOKEN>
<TOKEN end_char="800" id="token-10-1" morph="none" pos="word" start_char="794">utiliza</TOKEN>
<TOKEN end_char="804" id="token-10-2" morph="none" pos="word" start_char="802">una</TOKEN>
<TOKEN end_char="815" id="token-10-3" morph="none" pos="word" start_char="806">plataforma</TOKEN>
<TOKEN end_char="818" id="token-10-4" morph="none" pos="word" start_char="817">de</TOKEN>
<TOKEN end_char="835" id="token-10-5" morph="none" pos="word" start_char="820">supercomputación</TOKEN>
<TOKEN end_char="840" id="token-10-6" morph="none" pos="word" start_char="837">para</TOKEN>
<TOKEN end_char="849" id="token-10-7" morph="none" pos="word" start_char="842">estudiar</TOKEN>
<TOKEN end_char="852" id="token-10-8" morph="none" pos="word" start_char="851">el</TOKEN>
<TOKEN end_char="860" id="token-10-9" morph="none" pos="word" start_char="854">impacto</TOKEN>
<TOKEN end_char="863" id="token-10-10" morph="none" pos="word" start_char="862">de</TOKEN>
<TOKEN end_char="873" id="token-10-11" morph="none" pos="word" start_char="865">moléculas</TOKEN>
<TOKEN end_char="883" id="token-10-12" morph="none" pos="word" start_char="875">conocidas</TOKEN>
<TOKEN end_char="890" id="token-10-13" morph="none" pos="word" start_char="885">frente</TOKEN>
<TOKEN end_char="893" id="token-10-14" morph="none" pos="word" start_char="892">al</TOKEN>
<TOKEN end_char="904" id="token-10-15" morph="none" pos="unknown" start_char="895">SARS-CoV-2</TOKEN>
<TOKEN end_char="905" id="token-10-16" morph="none" pos="punct" start_char="905">.</TOKEN>
<TRANSLATED_TEXT>It uses a supercomputing platform to study the impact of known molecules against SARS-CoV-2.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1047" id="segment-11" start_char="907">
<ORIGINAL_TEXT>Los investigadores creen que podría usarse en pacientes infectados que muestren una clínica leve para detener la propagación de la infección.</ORIGINAL_TEXT>
<TOKEN end_char="909" id="token-11-0" morph="none" pos="word" start_char="907">Los</TOKEN>
<TOKEN end_char="924" id="token-11-1" morph="none" pos="word" start_char="911">investigadores</TOKEN>
<TOKEN end_char="930" id="token-11-2" morph="none" pos="word" start_char="926">creen</TOKEN>
<TOKEN end_char="934" id="token-11-3" morph="none" pos="word" start_char="932">que</TOKEN>
<TOKEN end_char="941" id="token-11-4" morph="none" pos="word" start_char="936">podría</TOKEN>
<TOKEN end_char="948" id="token-11-5" morph="none" pos="word" start_char="943">usarse</TOKEN>
<TOKEN end_char="951" id="token-11-6" morph="none" pos="word" start_char="950">en</TOKEN>
<TOKEN end_char="961" id="token-11-7" morph="none" pos="word" start_char="953">pacientes</TOKEN>
<TOKEN end_char="972" id="token-11-8" morph="none" pos="word" start_char="963">infectados</TOKEN>
<TOKEN end_char="976" id="token-11-9" morph="none" pos="word" start_char="974">que</TOKEN>
<TOKEN end_char="985" id="token-11-10" morph="none" pos="word" start_char="978">muestren</TOKEN>
<TOKEN end_char="989" id="token-11-11" morph="none" pos="word" start_char="987">una</TOKEN>
<TOKEN end_char="997" id="token-11-12" morph="none" pos="word" start_char="991">clínica</TOKEN>
<TOKEN end_char="1002" id="token-11-13" morph="none" pos="word" start_char="999">leve</TOKEN>
<TOKEN end_char="1007" id="token-11-14" morph="none" pos="word" start_char="1004">para</TOKEN>
<TOKEN end_char="1015" id="token-11-15" morph="none" pos="word" start_char="1009">detener</TOKEN>
<TOKEN end_char="1018" id="token-11-16" morph="none" pos="word" start_char="1017">la</TOKEN>
<TOKEN end_char="1030" id="token-11-17" morph="none" pos="word" start_char="1020">propagación</TOKEN>
<TOKEN end_char="1033" id="token-11-18" morph="none" pos="word" start_char="1032">de</TOKEN>
<TOKEN end_char="1036" id="token-11-19" morph="none" pos="word" start_char="1035">la</TOKEN>
<TOKEN end_char="1046" id="token-11-20" morph="none" pos="word" start_char="1038">infección</TOKEN>
<TOKEN end_char="1047" id="token-11-21" morph="none" pos="punct" start_char="1047">.</TOKEN>
<TRANSLATED_TEXT>Researchers believe it could be used in infected patients who show a light clinic to stop the spread of the infection.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1145" id="segment-12" start_char="1049">
<ORIGINAL_TEXT>Además, el raloxifeno ha demostrado ser efectivo contra el MERS y el SARS en pruebas preclínicas.</ORIGINAL_TEXT>
<TOKEN end_char="1054" id="token-12-0" morph="none" pos="word" start_char="1049">Además</TOKEN>
<TOKEN end_char="1055" id="token-12-1" morph="none" pos="punct" start_char="1055">,</TOKEN>
<TOKEN end_char="1058" id="token-12-2" morph="none" pos="word" start_char="1057">el</TOKEN>
<TOKEN end_char="1069" id="token-12-3" morph="none" pos="word" start_char="1060">raloxifeno</TOKEN>
<TOKEN end_char="1072" id="token-12-4" morph="none" pos="word" start_char="1071">ha</TOKEN>
<TOKEN end_char="1083" id="token-12-5" morph="none" pos="word" start_char="1074">demostrado</TOKEN>
<TOKEN end_char="1087" id="token-12-6" morph="none" pos="word" start_char="1085">ser</TOKEN>
<TOKEN end_char="1096" id="token-12-7" morph="none" pos="word" start_char="1089">efectivo</TOKEN>
<TOKEN end_char="1103" id="token-12-8" morph="none" pos="word" start_char="1098">contra</TOKEN>
<TOKEN end_char="1106" id="token-12-9" morph="none" pos="word" start_char="1105">el</TOKEN>
<TOKEN end_char="1111" id="token-12-10" morph="none" pos="word" start_char="1108">MERS</TOKEN>
<TOKEN end_char="1113" id="token-12-11" morph="none" pos="word" start_char="1113">y</TOKEN>
<TOKEN end_char="1116" id="token-12-12" morph="none" pos="word" start_char="1115">el</TOKEN>
<TOKEN end_char="1121" id="token-12-13" morph="none" pos="word" start_char="1118">SARS</TOKEN>
<TOKEN end_char="1124" id="token-12-14" morph="none" pos="word" start_char="1123">en</TOKEN>
<TOKEN end_char="1132" id="token-12-15" morph="none" pos="word" start_char="1126">pruebas</TOKEN>
<TOKEN end_char="1144" id="token-12-16" morph="none" pos="word" start_char="1134">preclínicas</TOKEN>
<TOKEN end_char="1145" id="token-12-17" morph="none" pos="punct" start_char="1145">.</TOKEN>
<TRANSLATED_TEXT>In addition, raloxifene has been shown to be effective against MERS and SARS in preclinical tests.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1229" id="segment-13" start_char="1148">
<ORIGINAL_TEXT>Se trata de un medicamento bien tolerado y con un perfil de seguridad ya conocido.</ORIGINAL_TEXT>
<TOKEN end_char="1149" id="token-13-0" morph="none" pos="word" start_char="1148">Se</TOKEN>
<TOKEN end_char="1155" id="token-13-1" morph="none" pos="word" start_char="1151">trata</TOKEN>
<TOKEN end_char="1158" id="token-13-2" morph="none" pos="word" start_char="1157">de</TOKEN>
<TOKEN end_char="1161" id="token-13-3" morph="none" pos="word" start_char="1160">un</TOKEN>
<TOKEN end_char="1173" id="token-13-4" morph="none" pos="word" start_char="1163">medicamento</TOKEN>
<TOKEN end_char="1178" id="token-13-5" morph="none" pos="word" start_char="1175">bien</TOKEN>
<TOKEN end_char="1187" id="token-13-6" morph="none" pos="word" start_char="1180">tolerado</TOKEN>
<TOKEN end_char="1189" id="token-13-7" morph="none" pos="word" start_char="1189">y</TOKEN>
<TOKEN end_char="1193" id="token-13-8" morph="none" pos="word" start_char="1191">con</TOKEN>
<TOKEN end_char="1196" id="token-13-9" morph="none" pos="word" start_char="1195">un</TOKEN>
<TOKEN end_char="1203" id="token-13-10" morph="none" pos="word" start_char="1198">perfil</TOKEN>
<TOKEN end_char="1206" id="token-13-11" morph="none" pos="word" start_char="1205">de</TOKEN>
<TOKEN end_char="1216" id="token-13-12" morph="none" pos="word" start_char="1208">seguridad</TOKEN>
<TOKEN end_char="1219" id="token-13-13" morph="none" pos="word" start_char="1218">ya</TOKEN>
<TOKEN end_char="1228" id="token-13-14" morph="none" pos="word" start_char="1221">conocido</TOKEN>
<TOKEN end_char="1229" id="token-13-15" morph="none" pos="punct" start_char="1229">.</TOKEN>
<TRANSLATED_TEXT>It is a well-tolerated drug with a well-known safety profile.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1596" id="segment-14" start_char="1231">
<ORIGINAL_TEXT>Los investigadores han propuesto probar este genérico en ensayos clínicos y ya trabajan con la Agencia Europea del Medicamento (EMA) para buscar el camino más rápido hasta alcanzar esos ensayos en humanos, según informa el consorcio Excalate4Cov, que está financiado por la Comisión Europea y cuenta entre sus miembros con el Centro de Supercomputación de Barcelona.</ORIGINAL_TEXT>
<TOKEN end_char="1233" id="token-14-0" morph="none" pos="word" start_char="1231">Los</TOKEN>
<TOKEN end_char="1248" id="token-14-1" morph="none" pos="word" start_char="1235">investigadores</TOKEN>
<TOKEN end_char="1252" id="token-14-2" morph="none" pos="word" start_char="1250">han</TOKEN>
<TOKEN end_char="1262" id="token-14-3" morph="none" pos="word" start_char="1254">propuesto</TOKEN>
<TOKEN end_char="1269" id="token-14-4" morph="none" pos="word" start_char="1264">probar</TOKEN>
<TOKEN end_char="1274" id="token-14-5" morph="none" pos="word" start_char="1271">este</TOKEN>
<TOKEN end_char="1283" id="token-14-6" morph="none" pos="word" start_char="1276">genérico</TOKEN>
<TOKEN end_char="1286" id="token-14-7" morph="none" pos="word" start_char="1285">en</TOKEN>
<TOKEN end_char="1294" id="token-14-8" morph="none" pos="word" start_char="1288">ensayos</TOKEN>
<TOKEN end_char="1303" id="token-14-9" morph="none" pos="word" start_char="1296">clínicos</TOKEN>
<TOKEN end_char="1305" id="token-14-10" morph="none" pos="word" start_char="1305">y</TOKEN>
<TOKEN end_char="1308" id="token-14-11" morph="none" pos="word" start_char="1307">ya</TOKEN>
<TOKEN end_char="1317" id="token-14-12" morph="none" pos="word" start_char="1310">trabajan</TOKEN>
<TOKEN end_char="1321" id="token-14-13" morph="none" pos="word" start_char="1319">con</TOKEN>
<TOKEN end_char="1324" id="token-14-14" morph="none" pos="word" start_char="1323">la</TOKEN>
<TOKEN end_char="1332" id="token-14-15" morph="none" pos="word" start_char="1326">Agencia</TOKEN>
<TOKEN end_char="1340" id="token-14-16" morph="none" pos="word" start_char="1334">Europea</TOKEN>
<TOKEN end_char="1344" id="token-14-17" morph="none" pos="word" start_char="1342">del</TOKEN>
<TOKEN end_char="1356" id="token-14-18" morph="none" pos="word" start_char="1346">Medicamento</TOKEN>
<TOKEN end_char="1358" id="token-14-19" morph="none" pos="punct" start_char="1358">(</TOKEN>
<TOKEN end_char="1361" id="token-14-20" morph="none" pos="word" start_char="1359">EMA</TOKEN>
<TOKEN end_char="1362" id="token-14-21" morph="none" pos="punct" start_char="1362">)</TOKEN>
<TOKEN end_char="1367" id="token-14-22" morph="none" pos="word" start_char="1364">para</TOKEN>
<TOKEN end_char="1374" id="token-14-23" morph="none" pos="word" start_char="1369">buscar</TOKEN>
<TOKEN end_char="1377" id="token-14-24" morph="none" pos="word" start_char="1376">el</TOKEN>
<TOKEN end_char="1384" id="token-14-25" morph="none" pos="word" start_char="1379">camino</TOKEN>
<TOKEN end_char="1388" id="token-14-26" morph="none" pos="word" start_char="1386">más</TOKEN>
<TOKEN end_char="1395" id="token-14-27" morph="none" pos="word" start_char="1390">rápido</TOKEN>
<TOKEN end_char="1401" id="token-14-28" morph="none" pos="word" start_char="1397">hasta</TOKEN>
<TOKEN end_char="1410" id="token-14-29" morph="none" pos="word" start_char="1403">alcanzar</TOKEN>
<TOKEN end_char="1415" id="token-14-30" morph="none" pos="word" start_char="1412">esos</TOKEN>
<TOKEN end_char="1423" id="token-14-31" morph="none" pos="word" start_char="1417">ensayos</TOKEN>
<TOKEN end_char="1426" id="token-14-32" morph="none" pos="word" start_char="1425">en</TOKEN>
<TOKEN end_char="1434" id="token-14-33" morph="none" pos="word" start_char="1428">humanos</TOKEN>
<TOKEN end_char="1435" id="token-14-34" morph="none" pos="punct" start_char="1435">,</TOKEN>
<TOKEN end_char="1441" id="token-14-35" morph="none" pos="word" start_char="1437">según</TOKEN>
<TOKEN end_char="1449" id="token-14-36" morph="none" pos="word" start_char="1443">informa</TOKEN>
<TOKEN end_char="1452" id="token-14-37" morph="none" pos="word" start_char="1451">el</TOKEN>
<TOKEN end_char="1462" id="token-14-38" morph="none" pos="word" start_char="1454">consorcio</TOKEN>
<TOKEN end_char="1475" id="token-14-39" morph="none" pos="word" start_char="1464">Excalate4Cov</TOKEN>
<TOKEN end_char="1476" id="token-14-40" morph="none" pos="punct" start_char="1476">,</TOKEN>
<TOKEN end_char="1480" id="token-14-41" morph="none" pos="word" start_char="1478">que</TOKEN>
<TOKEN end_char="1485" id="token-14-42" morph="none" pos="word" start_char="1482">está</TOKEN>
<TOKEN end_char="1496" id="token-14-43" morph="none" pos="word" start_char="1487">financiado</TOKEN>
<TOKEN end_char="1500" id="token-14-44" morph="none" pos="word" start_char="1498">por</TOKEN>
<TOKEN end_char="1503" id="token-14-45" morph="none" pos="word" start_char="1502">la</TOKEN>
<TOKEN end_char="1512" id="token-14-46" morph="none" pos="word" start_char="1505">Comisión</TOKEN>
<TOKEN end_char="1520" id="token-14-47" morph="none" pos="word" start_char="1514">Europea</TOKEN>
<TOKEN end_char="1522" id="token-14-48" morph="none" pos="word" start_char="1522">y</TOKEN>
<TOKEN end_char="1529" id="token-14-49" morph="none" pos="word" start_char="1524">cuenta</TOKEN>
<TOKEN end_char="1535" id="token-14-50" morph="none" pos="word" start_char="1531">entre</TOKEN>
<TOKEN end_char="1539" id="token-14-51" morph="none" pos="word" start_char="1537">sus</TOKEN>
<TOKEN end_char="1548" id="token-14-52" morph="none" pos="word" start_char="1541">miembros</TOKEN>
<TOKEN end_char="1552" id="token-14-53" morph="none" pos="word" start_char="1550">con</TOKEN>
<TOKEN end_char="1555" id="token-14-54" morph="none" pos="word" start_char="1554">el</TOKEN>
<TOKEN end_char="1562" id="token-14-55" morph="none" pos="word" start_char="1557">Centro</TOKEN>
<TOKEN end_char="1565" id="token-14-56" morph="none" pos="word" start_char="1564">de</TOKEN>
<TOKEN end_char="1582" id="token-14-57" morph="none" pos="word" start_char="1567">Supercomputación</TOKEN>
<TOKEN end_char="1585" id="token-14-58" morph="none" pos="word" start_char="1584">de</TOKEN>
<TOKEN end_char="1595" id="token-14-59" morph="none" pos="word" start_char="1587">Barcelona</TOKEN>
<TOKEN end_char="1596" id="token-14-60" morph="none" pos="punct" start_char="1596">.</TOKEN>
<TRANSLATED_TEXT>Researchers have proposed to test this generic in clinical trials and are already working with the European Medicines Agency (EMA) to find the quickest way to achieve those trials in humans, according to the Excalate4Cov consortium, which is funded by the European Commission and whose members include the Barcelona Supercomputing Centre.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1703" id="segment-15" start_char="1598">
<ORIGINAL_TEXT>En caso de éxito, el medicamento podría estar rápidamente disponible en volúmenes elevados y a bajo coste.</ORIGINAL_TEXT>
<TOKEN end_char="1599" id="token-15-0" morph="none" pos="word" start_char="1598">En</TOKEN>
<TOKEN end_char="1604" id="token-15-1" morph="none" pos="word" start_char="1601">caso</TOKEN>
<TOKEN end_char="1607" id="token-15-2" morph="none" pos="word" start_char="1606">de</TOKEN>
<TOKEN end_char="1613" id="token-15-3" morph="none" pos="word" start_char="1609">éxito</TOKEN>
<TOKEN end_char="1614" id="token-15-4" morph="none" pos="punct" start_char="1614">,</TOKEN>
<TOKEN end_char="1617" id="token-15-5" morph="none" pos="word" start_char="1616">el</TOKEN>
<TOKEN end_char="1629" id="token-15-6" morph="none" pos="word" start_char="1619">medicamento</TOKEN>
<TOKEN end_char="1636" id="token-15-7" morph="none" pos="word" start_char="1631">podría</TOKEN>
<TOKEN end_char="1642" id="token-15-8" morph="none" pos="word" start_char="1638">estar</TOKEN>
<TOKEN end_char="1654" id="token-15-9" morph="none" pos="word" start_char="1644">rápidamente</TOKEN>
<TOKEN end_char="1665" id="token-15-10" morph="none" pos="word" start_char="1656">disponible</TOKEN>
<TOKEN end_char="1668" id="token-15-11" morph="none" pos="word" start_char="1667">en</TOKEN>
<TOKEN end_char="1678" id="token-15-12" morph="none" pos="word" start_char="1670">volúmenes</TOKEN>
<TOKEN end_char="1687" id="token-15-13" morph="none" pos="word" start_char="1680">elevados</TOKEN>
<TOKEN end_char="1689" id="token-15-14" morph="none" pos="word" start_char="1689">y</TOKEN>
<TOKEN end_char="1691" id="token-15-15" morph="none" pos="word" start_char="1691">a</TOKEN>
<TOKEN end_char="1696" id="token-15-16" morph="none" pos="word" start_char="1693">bajo</TOKEN>
<TOKEN end_char="1702" id="token-15-17" morph="none" pos="word" start_char="1698">coste</TOKEN>
<TOKEN end_char="1703" id="token-15-18" morph="none" pos="punct" start_char="1703">.</TOKEN>
<TRANSLATED_TEXT>If successful, the drug might be quickly available in high volumes and at low cost.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1805" id="segment-16" start_char="1706">
<ORIGINAL_TEXT>Los investigadores han propuesto probar el raloxifeno en casos leves de Covid-19 en ensayos clínicos</ORIGINAL_TEXT>
<TOKEN end_char="1708" id="token-16-0" morph="none" pos="word" start_char="1706">Los</TOKEN>
<TOKEN end_char="1723" id="token-16-1" morph="none" pos="word" start_char="1710">investigadores</TOKEN>
<TOKEN end_char="1727" id="token-16-2" morph="none" pos="word" start_char="1725">han</TOKEN>
<TOKEN end_char="1737" id="token-16-3" morph="none" pos="word" start_char="1729">propuesto</TOKEN>
<TOKEN end_char="1744" id="token-16-4" morph="none" pos="word" start_char="1739">probar</TOKEN>
<TOKEN end_char="1747" id="token-16-5" morph="none" pos="word" start_char="1746">el</TOKEN>
<TOKEN end_char="1758" id="token-16-6" morph="none" pos="word" start_char="1749">raloxifeno</TOKEN>
<TOKEN end_char="1761" id="token-16-7" morph="none" pos="word" start_char="1760">en</TOKEN>
<TOKEN end_char="1767" id="token-16-8" morph="none" pos="word" start_char="1763">casos</TOKEN>
<TOKEN end_char="1773" id="token-16-9" morph="none" pos="word" start_char="1769">leves</TOKEN>
<TOKEN end_char="1776" id="token-16-10" morph="none" pos="word" start_char="1775">de</TOKEN>
<TOKEN end_char="1785" id="token-16-11" morph="none" pos="unknown" start_char="1778">Covid-19</TOKEN>
<TOKEN end_char="1788" id="token-16-12" morph="none" pos="word" start_char="1787">en</TOKEN>
<TOKEN end_char="1796" id="token-16-13" morph="none" pos="word" start_char="1790">ensayos</TOKEN>
<TOKEN end_char="1805" id="token-16-14" morph="none" pos="word" start_char="1798">clínicos</TOKEN>
<TRANSLATED_TEXT>Researchers have proposed to test raloxifene in mild cases of Covid-19 in clinical trials</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1975" id="segment-17" start_char="1809">
<ORIGINAL_TEXT>La conclusión de los buenos resultados que podrían darse con raloxifeno se alcanzó tras la prueba de simulación computacional con más de 400.000 moléculas disponibles.</ORIGINAL_TEXT>
<TOKEN end_char="1810" id="token-17-0" morph="none" pos="word" start_char="1809">La</TOKEN>
<TOKEN end_char="1821" id="token-17-1" morph="none" pos="word" start_char="1812">conclusión</TOKEN>
<TOKEN end_char="1824" id="token-17-2" morph="none" pos="word" start_char="1823">de</TOKEN>
<TOKEN end_char="1828" id="token-17-3" morph="none" pos="word" start_char="1826">los</TOKEN>
<TOKEN end_char="1835" id="token-17-4" morph="none" pos="word" start_char="1830">buenos</TOKEN>
<TOKEN end_char="1846" id="token-17-5" morph="none" pos="word" start_char="1837">resultados</TOKEN>
<TOKEN end_char="1850" id="token-17-6" morph="none" pos="word" start_char="1848">que</TOKEN>
<TOKEN end_char="1858" id="token-17-7" morph="none" pos="word" start_char="1852">podrían</TOKEN>
<TOKEN end_char="1864" id="token-17-8" morph="none" pos="word" start_char="1860">darse</TOKEN>
<TOKEN end_char="1868" id="token-17-9" morph="none" pos="word" start_char="1866">con</TOKEN>
<TOKEN end_char="1879" id="token-17-10" morph="none" pos="word" start_char="1870">raloxifeno</TOKEN>
<TOKEN end_char="1882" id="token-17-11" morph="none" pos="word" start_char="1881">se</TOKEN>
<TOKEN end_char="1890" id="token-17-12" morph="none" pos="word" start_char="1884">alcanzó</TOKEN>
<TOKEN end_char="1895" id="token-17-13" morph="none" pos="word" start_char="1892">tras</TOKEN>
<TOKEN end_char="1898" id="token-17-14" morph="none" pos="word" start_char="1897">la</TOKEN>
<TOKEN end_char="1905" id="token-17-15" morph="none" pos="word" start_char="1900">prueba</TOKEN>
<TOKEN end_char="1908" id="token-17-16" morph="none" pos="word" start_char="1907">de</TOKEN>
<TOKEN end_char="1919" id="token-17-17" morph="none" pos="word" start_char="1910">simulación</TOKEN>
<TOKEN end_char="1933" id="token-17-18" morph="none" pos="word" start_char="1921">computacional</TOKEN>
<TOKEN end_char="1937" id="token-17-19" morph="none" pos="word" start_char="1935">con</TOKEN>
<TOKEN end_char="1941" id="token-17-20" morph="none" pos="word" start_char="1939">más</TOKEN>
<TOKEN end_char="1944" id="token-17-21" morph="none" pos="word" start_char="1943">de</TOKEN>
<TOKEN end_char="1952" id="token-17-22" morph="none" pos="word" start_char="1946">400.000</TOKEN>
<TOKEN end_char="1962" id="token-17-23" morph="none" pos="word" start_char="1954">moléculas</TOKEN>
<TOKEN end_char="1974" id="token-17-24" morph="none" pos="word" start_char="1964">disponibles</TOKEN>
<TOKEN end_char="1975" id="token-17-25" morph="none" pos="punct" start_char="1975">.</TOKEN>
<TRANSLATED_TEXT>The conclusion of the good results that could be achieved with raloxifene was reached after computer simulation testing with more than 400,000 molecules available.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2047" id="segment-18" start_char="1977">
<ORIGINAL_TEXT>Se priorizaron aquellas que ya estaban en el mercado o en fase clínica.</ORIGINAL_TEXT>
<TOKEN end_char="1978" id="token-18-0" morph="none" pos="word" start_char="1977">Se</TOKEN>
<TOKEN end_char="1990" id="token-18-1" morph="none" pos="word" start_char="1980">priorizaron</TOKEN>
<TOKEN end_char="1999" id="token-18-2" morph="none" pos="word" start_char="1992">aquellas</TOKEN>
<TOKEN end_char="2003" id="token-18-3" morph="none" pos="word" start_char="2001">que</TOKEN>
<TOKEN end_char="2006" id="token-18-4" morph="none" pos="word" start_char="2005">ya</TOKEN>
<TOKEN end_char="2014" id="token-18-5" morph="none" pos="word" start_char="2008">estaban</TOKEN>
<TOKEN end_char="2017" id="token-18-6" morph="none" pos="word" start_char="2016">en</TOKEN>
<TOKEN end_char="2020" id="token-18-7" morph="none" pos="word" start_char="2019">el</TOKEN>
<TOKEN end_char="2028" id="token-18-8" morph="none" pos="word" start_char="2022">mercado</TOKEN>
<TOKEN end_char="2030" id="token-18-9" morph="none" pos="word" start_char="2030">o</TOKEN>
<TOKEN end_char="2033" id="token-18-10" morph="none" pos="word" start_char="2032">en</TOKEN>
<TOKEN end_char="2038" id="token-18-11" morph="none" pos="word" start_char="2035">fase</TOKEN>
<TOKEN end_char="2046" id="token-18-12" morph="none" pos="word" start_char="2040">clínica</TOKEN>
<TOKEN end_char="2047" id="token-18-13" morph="none" pos="punct" start_char="2047">.</TOKEN>
<TRANSLATED_TEXT>Those already in the market or clinical phase were prioritized.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2165" id="segment-19" start_char="2049">
<ORIGINAL_TEXT>Se preseleccionaron 7.000 moléculas que contaban con características que podrían ser prometedoras frente al Covid-19.</ORIGINAL_TEXT>
<TOKEN end_char="2050" id="token-19-0" morph="none" pos="word" start_char="2049">Se</TOKEN>
<TOKEN end_char="2067" id="token-19-1" morph="none" pos="word" start_char="2052">preseleccionaron</TOKEN>
<TOKEN end_char="2073" id="token-19-2" morph="none" pos="word" start_char="2069">7.000</TOKEN>
<TOKEN end_char="2083" id="token-19-3" morph="none" pos="word" start_char="2075">moléculas</TOKEN>
<TOKEN end_char="2087" id="token-19-4" morph="none" pos="word" start_char="2085">que</TOKEN>
<TOKEN end_char="2096" id="token-19-5" morph="none" pos="word" start_char="2089">contaban</TOKEN>
<TOKEN end_char="2100" id="token-19-6" morph="none" pos="word" start_char="2098">con</TOKEN>
<TOKEN end_char="2116" id="token-19-7" morph="none" pos="word" start_char="2102">características</TOKEN>
<TOKEN end_char="2120" id="token-19-8" morph="none" pos="word" start_char="2118">que</TOKEN>
<TOKEN end_char="2128" id="token-19-9" morph="none" pos="word" start_char="2122">podrían</TOKEN>
<TOKEN end_char="2132" id="token-19-10" morph="none" pos="word" start_char="2130">ser</TOKEN>
<TOKEN end_char="2145" id="token-19-11" morph="none" pos="word" start_char="2134">prometedoras</TOKEN>
<TOKEN end_char="2152" id="token-19-12" morph="none" pos="word" start_char="2147">frente</TOKEN>
<TOKEN end_char="2155" id="token-19-13" morph="none" pos="word" start_char="2154">al</TOKEN>
<TOKEN end_char="2164" id="token-19-14" morph="none" pos="unknown" start_char="2157">Covid-19</TOKEN>
<TOKEN end_char="2165" id="token-19-15" morph="none" pos="punct" start_char="2165">.</TOKEN>
<TRANSLATED_TEXT>Seven thousand molecules were pre-selected with characteristics that could be promising against Covid-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2371" id="segment-20" start_char="2168">
<ORIGINAL_TEXT>Según informa el consorcio, la protección intelectual del fármaco para su uso frente al Covid-19 se ha registrado en nombre de Dompé farmaceutici, Fraunhofer Institute y KU Leuven, miembros del consorcio,</ORIGINAL_TEXT>
<TOKEN end_char="2172" id="token-20-0" morph="none" pos="word" start_char="2168">Según</TOKEN>
<TOKEN end_char="2180" id="token-20-1" morph="none" pos="word" start_char="2174">informa</TOKEN>
<TOKEN end_char="2183" id="token-20-2" morph="none" pos="word" start_char="2182">el</TOKEN>
<TOKEN end_char="2193" id="token-20-3" morph="none" pos="word" start_char="2185">consorcio</TOKEN>
<TOKEN end_char="2194" id="token-20-4" morph="none" pos="punct" start_char="2194">,</TOKEN>
<TOKEN end_char="2197" id="token-20-5" morph="none" pos="word" start_char="2196">la</TOKEN>
<TOKEN end_char="2208" id="token-20-6" morph="none" pos="word" start_char="2199">protección</TOKEN>
<TOKEN end_char="2220" id="token-20-7" morph="none" pos="word" start_char="2210">intelectual</TOKEN>
<TOKEN end_char="2224" id="token-20-8" morph="none" pos="word" start_char="2222">del</TOKEN>
<TOKEN end_char="2232" id="token-20-9" morph="none" pos="word" start_char="2226">fármaco</TOKEN>
<TOKEN end_char="2237" id="token-20-10" morph="none" pos="word" start_char="2234">para</TOKEN>
<TOKEN end_char="2240" id="token-20-11" morph="none" pos="word" start_char="2239">su</TOKEN>
<TOKEN end_char="2244" id="token-20-12" morph="none" pos="word" start_char="2242">uso</TOKEN>
<TOKEN end_char="2251" id="token-20-13" morph="none" pos="word" start_char="2246">frente</TOKEN>
<TOKEN end_char="2254" id="token-20-14" morph="none" pos="word" start_char="2253">al</TOKEN>
<TOKEN end_char="2263" id="token-20-15" morph="none" pos="unknown" start_char="2256">Covid-19</TOKEN>
<TOKEN end_char="2266" id="token-20-16" morph="none" pos="word" start_char="2265">se</TOKEN>
<TOKEN end_char="2269" id="token-20-17" morph="none" pos="word" start_char="2268">ha</TOKEN>
<TOKEN end_char="2280" id="token-20-18" morph="none" pos="word" start_char="2271">registrado</TOKEN>
<TOKEN end_char="2283" id="token-20-19" morph="none" pos="word" start_char="2282">en</TOKEN>
<TOKEN end_char="2290" id="token-20-20" morph="none" pos="word" start_char="2285">nombre</TOKEN>
<TOKEN end_char="2293" id="token-20-21" morph="none" pos="word" start_char="2292">de</TOKEN>
<TOKEN end_char="2299" id="token-20-22" morph="none" pos="word" start_char="2295">Dompé</TOKEN>
<TOKEN end_char="2312" id="token-20-23" morph="none" pos="word" start_char="2301">farmaceutici</TOKEN>
<TOKEN end_char="2313" id="token-20-24" morph="none" pos="punct" start_char="2313">,</TOKEN>
<TOKEN end_char="2324" id="token-20-25" morph="none" pos="word" start_char="2315">Fraunhofer</TOKEN>
<TOKEN end_char="2334" id="token-20-26" morph="none" pos="word" start_char="2326">Institute</TOKEN>
<TOKEN end_char="2336" id="token-20-27" morph="none" pos="word" start_char="2336">y</TOKEN>
<TOKEN end_char="2339" id="token-20-28" morph="none" pos="word" start_char="2338">KU</TOKEN>
<TOKEN end_char="2346" id="token-20-29" morph="none" pos="word" start_char="2341">Leuven</TOKEN>
<TOKEN end_char="2347" id="token-20-30" morph="none" pos="punct" start_char="2347">,</TOKEN>
<TOKEN end_char="2356" id="token-20-31" morph="none" pos="word" start_char="2349">miembros</TOKEN>
<TOKEN end_char="2360" id="token-20-32" morph="none" pos="word" start_char="2358">del</TOKEN>
<TOKEN end_char="2370" id="token-20-33" morph="none" pos="word" start_char="2362">consorcio</TOKEN>
<TOKEN end_char="2371" id="token-20-34" morph="none" pos="punct" start_char="2371">,</TOKEN>
<TRANSLATED_TEXT>According to the consortium, the intellectual protection of the drug for its use against Covid-19 has been registered on behalf of Dompé Pharmaceuticals, Fraunhofer Institute and KU Leuven, members of the consortium,</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2408" id="segment-21" start_char="2374">
<ORIGINAL_TEXT>"para promover el acceso universal"</ORIGINAL_TEXT>
<TOKEN end_char="2374" id="token-21-0" morph="none" pos="punct" start_char="2374">"</TOKEN>
<TOKEN end_char="2378" id="token-21-1" morph="none" pos="word" start_char="2375">para</TOKEN>
<TOKEN end_char="2387" id="token-21-2" morph="none" pos="word" start_char="2380">promover</TOKEN>
<TOKEN end_char="2390" id="token-21-3" morph="none" pos="word" start_char="2389">el</TOKEN>
<TOKEN end_char="2397" id="token-21-4" morph="none" pos="word" start_char="2392">acceso</TOKEN>
<TOKEN end_char="2407" id="token-21-5" morph="none" pos="word" start_char="2399">universal</TOKEN>
<TOKEN end_char="2408" id="token-21-6" morph="none" pos="punct" start_char="2408">"</TOKEN>
<TRANSLATED_TEXT>to promote universal access</TRANSLATED_TEXT><DETECTED_LANGUAGE>it</DETECTED_LANGUAGE></SEG>
<SEG end_char="2425" id="segment-22" start_char="2411">
<ORIGINAL_TEXT>al medicamento.</ORIGINAL_TEXT>
<TOKEN end_char="2412" id="token-22-0" morph="none" pos="word" start_char="2411">al</TOKEN>
<TOKEN end_char="2424" id="token-22-1" morph="none" pos="word" start_char="2414">medicamento</TOKEN>
<TOKEN end_char="2425" id="token-22-2" morph="none" pos="punct" start_char="2425">.</TOKEN>
<TRANSLATED_TEXT>the medicine.</TRANSLATED_TEXT><DETECTED_LANGUAGE>it</DETECTED_LANGUAGE></SEG>
<SEG end_char="2515" id="segment-23" start_char="2427">
<ORIGINAL_TEXT>Además, todos los datos científicos producidos por el consorcio serán de dominio público.</ORIGINAL_TEXT>
<TOKEN end_char="2432" id="token-23-0" morph="none" pos="word" start_char="2427">Además</TOKEN>
<TOKEN end_char="2433" id="token-23-1" morph="none" pos="punct" start_char="2433">,</TOKEN>
<TOKEN end_char="2439" id="token-23-2" morph="none" pos="word" start_char="2435">todos</TOKEN>
<TOKEN end_char="2443" id="token-23-3" morph="none" pos="word" start_char="2441">los</TOKEN>
<TOKEN end_char="2449" id="token-23-4" morph="none" pos="word" start_char="2445">datos</TOKEN>
<TOKEN end_char="2461" id="token-23-5" morph="none" pos="word" start_char="2451">científicos</TOKEN>
<TOKEN end_char="2472" id="token-23-6" morph="none" pos="word" start_char="2463">producidos</TOKEN>
<TOKEN end_char="2476" id="token-23-7" morph="none" pos="word" start_char="2474">por</TOKEN>
<TOKEN end_char="2479" id="token-23-8" morph="none" pos="word" start_char="2478">el</TOKEN>
<TOKEN end_char="2489" id="token-23-9" morph="none" pos="word" start_char="2481">consorcio</TOKEN>
<TOKEN end_char="2495" id="token-23-10" morph="none" pos="word" start_char="2491">serán</TOKEN>
<TOKEN end_char="2498" id="token-23-11" morph="none" pos="word" start_char="2497">de</TOKEN>
<TOKEN end_char="2506" id="token-23-12" morph="none" pos="word" start_char="2500">dominio</TOKEN>
<TOKEN end_char="2514" id="token-23-13" morph="none" pos="word" start_char="2508">público</TOKEN>
<TOKEN end_char="2515" id="token-23-14" morph="none" pos="punct" start_char="2515">.</TOKEN>
<TRANSLATED_TEXT>In addition, all scientific data produced by the consortium will be in the public domain.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2683" id="segment-24" start_char="2518">
<ORIGINAL_TEXT>La conclusión de los buenos resultados que podrían darse con raloxifeno se alcanzó tras la prueba de simulación computacional con más de 400.000 moléculas disponibles</ORIGINAL_TEXT>
<TOKEN end_char="2519" id="token-24-0" morph="none" pos="word" start_char="2518">La</TOKEN>
<TOKEN end_char="2530" id="token-24-1" morph="none" pos="word" start_char="2521">conclusión</TOKEN>
<TOKEN end_char="2533" id="token-24-2" morph="none" pos="word" start_char="2532">de</TOKEN>
<TOKEN end_char="2537" id="token-24-3" morph="none" pos="word" start_char="2535">los</TOKEN>
<TOKEN end_char="2544" id="token-24-4" morph="none" pos="word" start_char="2539">buenos</TOKEN>
<TOKEN end_char="2555" id="token-24-5" morph="none" pos="word" start_char="2546">resultados</TOKEN>
<TOKEN end_char="2559" id="token-24-6" morph="none" pos="word" start_char="2557">que</TOKEN>
<TOKEN end_char="2567" id="token-24-7" morph="none" pos="word" start_char="2561">podrían</TOKEN>
<TOKEN end_char="2573" id="token-24-8" morph="none" pos="word" start_char="2569">darse</TOKEN>
<TOKEN end_char="2577" id="token-24-9" morph="none" pos="word" start_char="2575">con</TOKEN>
<TOKEN end_char="2588" id="token-24-10" morph="none" pos="word" start_char="2579">raloxifeno</TOKEN>
<TOKEN end_char="2591" id="token-24-11" morph="none" pos="word" start_char="2590">se</TOKEN>
<TOKEN end_char="2599" id="token-24-12" morph="none" pos="word" start_char="2593">alcanzó</TOKEN>
<TOKEN end_char="2604" id="token-24-13" morph="none" pos="word" start_char="2601">tras</TOKEN>
<TOKEN end_char="2607" id="token-24-14" morph="none" pos="word" start_char="2606">la</TOKEN>
<TOKEN end_char="2614" id="token-24-15" morph="none" pos="word" start_char="2609">prueba</TOKEN>
<TOKEN end_char="2617" id="token-24-16" morph="none" pos="word" start_char="2616">de</TOKEN>
<TOKEN end_char="2628" id="token-24-17" morph="none" pos="word" start_char="2619">simulación</TOKEN>
<TOKEN end_char="2642" id="token-24-18" morph="none" pos="word" start_char="2630">computacional</TOKEN>
<TOKEN end_char="2646" id="token-24-19" morph="none" pos="word" start_char="2644">con</TOKEN>
<TOKEN end_char="2650" id="token-24-20" morph="none" pos="word" start_char="2648">más</TOKEN>
<TOKEN end_char="2653" id="token-24-21" morph="none" pos="word" start_char="2652">de</TOKEN>
<TOKEN end_char="2661" id="token-24-22" morph="none" pos="word" start_char="2655">400.000</TOKEN>
<TOKEN end_char="2671" id="token-24-23" morph="none" pos="word" start_char="2663">moléculas</TOKEN>
<TOKEN end_char="2683" id="token-24-24" morph="none" pos="word" start_char="2673">disponibles</TOKEN>
<TRANSLATED_TEXT>The conclusion of the good results that could be achieved with raloxifene was reached after the computational simulation test with more than 400,000 molecules available</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2889" id="segment-25" start_char="2687">
<ORIGINAL_TEXT>Al utilizar una plataforma europea de supercomputación, una de las más potentes del mundo, Exscalate4CoV puede llevar a cabo en semanas un proceso de cribado que con técnicas tradicionales llevaría años.</ORIGINAL_TEXT>
<TOKEN end_char="2688" id="token-25-0" morph="none" pos="word" start_char="2687">Al</TOKEN>
<TOKEN end_char="2697" id="token-25-1" morph="none" pos="word" start_char="2690">utilizar</TOKEN>
<TOKEN end_char="2701" id="token-25-2" morph="none" pos="word" start_char="2699">una</TOKEN>
<TOKEN end_char="2712" id="token-25-3" morph="none" pos="word" start_char="2703">plataforma</TOKEN>
<TOKEN end_char="2720" id="token-25-4" morph="none" pos="word" start_char="2714">europea</TOKEN>
<TOKEN end_char="2723" id="token-25-5" morph="none" pos="word" start_char="2722">de</TOKEN>
<TOKEN end_char="2740" id="token-25-6" morph="none" pos="word" start_char="2725">supercomputación</TOKEN>
<TOKEN end_char="2741" id="token-25-7" morph="none" pos="punct" start_char="2741">,</TOKEN>
<TOKEN end_char="2745" id="token-25-8" morph="none" pos="word" start_char="2743">una</TOKEN>
<TOKEN end_char="2748" id="token-25-9" morph="none" pos="word" start_char="2747">de</TOKEN>
<TOKEN end_char="2752" id="token-25-10" morph="none" pos="word" start_char="2750">las</TOKEN>
<TOKEN end_char="2756" id="token-25-11" morph="none" pos="word" start_char="2754">más</TOKEN>
<TOKEN end_char="2765" id="token-25-12" morph="none" pos="word" start_char="2758">potentes</TOKEN>
<TOKEN end_char="2769" id="token-25-13" morph="none" pos="word" start_char="2767">del</TOKEN>
<TOKEN end_char="2775" id="token-25-14" morph="none" pos="word" start_char="2771">mundo</TOKEN>
<TOKEN end_char="2776" id="token-25-15" morph="none" pos="punct" start_char="2776">,</TOKEN>
<TOKEN end_char="2790" id="token-25-16" morph="none" pos="word" start_char="2778">Exscalate4CoV</TOKEN>
<TOKEN end_char="2796" id="token-25-17" morph="none" pos="word" start_char="2792">puede</TOKEN>
<TOKEN end_char="2803" id="token-25-18" morph="none" pos="word" start_char="2798">llevar</TOKEN>
<TOKEN end_char="2805" id="token-25-19" morph="none" pos="word" start_char="2805">a</TOKEN>
<TOKEN end_char="2810" id="token-25-20" morph="none" pos="word" start_char="2807">cabo</TOKEN>
<TOKEN end_char="2813" id="token-25-21" morph="none" pos="word" start_char="2812">en</TOKEN>
<TOKEN end_char="2821" id="token-25-22" morph="none" pos="word" start_char="2815">semanas</TOKEN>
<TOKEN end_char="2824" id="token-25-23" morph="none" pos="word" start_char="2823">un</TOKEN>
<TOKEN end_char="2832" id="token-25-24" morph="none" pos="word" start_char="2826">proceso</TOKEN>
<TOKEN end_char="2835" id="token-25-25" morph="none" pos="word" start_char="2834">de</TOKEN>
<TOKEN end_char="2843" id="token-25-26" morph="none" pos="word" start_char="2837">cribado</TOKEN>
<TOKEN end_char="2847" id="token-25-27" morph="none" pos="word" start_char="2845">que</TOKEN>
<TOKEN end_char="2851" id="token-25-28" morph="none" pos="word" start_char="2849">con</TOKEN>
<TOKEN end_char="2860" id="token-25-29" morph="none" pos="word" start_char="2853">técnicas</TOKEN>
<TOKEN end_char="2874" id="token-25-30" morph="none" pos="word" start_char="2862">tradicionales</TOKEN>
<TOKEN end_char="2883" id="token-25-31" morph="none" pos="word" start_char="2876">llevaría</TOKEN>
<TOKEN end_char="2888" id="token-25-32" morph="none" pos="word" start_char="2885">años</TOKEN>
<TOKEN end_char="2889" id="token-25-33" morph="none" pos="punct" start_char="2889">.</TOKEN>
<TRANSLATED_TEXT>Using a European supercomputing platform, one of the most powerful in the world, Exscalate4CoV can carry out a screening process that with traditional techniques would take years.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3031" id="segment-26" start_char="2891">
<ORIGINAL_TEXT>En una primera fase, ha identificado ya seis de los 25 modelos distintos de proteínas del nuevo coronavirus que están en constante evolución.</ORIGINAL_TEXT>
<TOKEN end_char="2892" id="token-26-0" morph="none" pos="word" start_char="2891">En</TOKEN>
<TOKEN end_char="2896" id="token-26-1" morph="none" pos="word" start_char="2894">una</TOKEN>
<TOKEN end_char="2904" id="token-26-2" morph="none" pos="word" start_char="2898">primera</TOKEN>
<TOKEN end_char="2909" id="token-26-3" morph="none" pos="word" start_char="2906">fase</TOKEN>
<TOKEN end_char="2910" id="token-26-4" morph="none" pos="punct" start_char="2910">,</TOKEN>
<TOKEN end_char="2913" id="token-26-5" morph="none" pos="word" start_char="2912">ha</TOKEN>
<TOKEN end_char="2926" id="token-26-6" morph="none" pos="word" start_char="2915">identificado</TOKEN>
<TOKEN end_char="2929" id="token-26-7" morph="none" pos="word" start_char="2928">ya</TOKEN>
<TOKEN end_char="2934" id="token-26-8" morph="none" pos="word" start_char="2931">seis</TOKEN>
<TOKEN end_char="2937" id="token-26-9" morph="none" pos="word" start_char="2936">de</TOKEN>
<TOKEN end_char="2941" id="token-26-10" morph="none" pos="word" start_char="2939">los</TOKEN>
<TOKEN end_char="2944" id="token-26-11" morph="none" pos="word" start_char="2943">25</TOKEN>
<TOKEN end_char="2952" id="token-26-12" morph="none" pos="word" start_char="2946">modelos</TOKEN>
<TOKEN end_char="2962" id="token-26-13" morph="none" pos="word" start_char="2954">distintos</TOKEN>
<TOKEN end_char="2965" id="token-26-14" morph="none" pos="word" start_char="2964">de</TOKEN>
<TOKEN end_char="2975" id="token-26-15" morph="none" pos="word" start_char="2967">proteínas</TOKEN>
<TOKEN end_char="2979" id="token-26-16" morph="none" pos="word" start_char="2977">del</TOKEN>
<TOKEN end_char="2985" id="token-26-17" morph="none" pos="word" start_char="2981">nuevo</TOKEN>
<TOKEN end_char="2997" id="token-26-18" morph="none" pos="word" start_char="2987">coronavirus</TOKEN>
<TOKEN end_char="3001" id="token-26-19" morph="none" pos="word" start_char="2999">que</TOKEN>
<TOKEN end_char="3007" id="token-26-20" morph="none" pos="word" start_char="3003">están</TOKEN>
<TOKEN end_char="3010" id="token-26-21" morph="none" pos="word" start_char="3009">en</TOKEN>
<TOKEN end_char="3020" id="token-26-22" morph="none" pos="word" start_char="3012">constante</TOKEN>
<TOKEN end_char="3030" id="token-26-23" morph="none" pos="word" start_char="3022">evolución</TOKEN>
<TOKEN end_char="3031" id="token-26-24" morph="none" pos="punct" start_char="3031">.</TOKEN>
<TRANSLATED_TEXT>In a first phase, he has already identified six of the 25 distinct protein models of the new coronavirus that are in constant evolution.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3145" id="segment-27" start_char="3033">
<ORIGINAL_TEXT>Además, recibe semanalmente varias mutaciones, que se traducen en forma digital para su uso en la fase siguiente.</ORIGINAL_TEXT>
<TOKEN end_char="3038" id="token-27-0" morph="none" pos="word" start_char="3033">Además</TOKEN>
<TOKEN end_char="3039" id="token-27-1" morph="none" pos="punct" start_char="3039">,</TOKEN>
<TOKEN end_char="3046" id="token-27-2" morph="none" pos="word" start_char="3041">recibe</TOKEN>
<TOKEN end_char="3059" id="token-27-3" morph="none" pos="word" start_char="3048">semanalmente</TOKEN>
<TOKEN end_char="3066" id="token-27-4" morph="none" pos="word" start_char="3061">varias</TOKEN>
<TOKEN end_char="3077" id="token-27-5" morph="none" pos="word" start_char="3068">mutaciones</TOKEN>
<TOKEN end_char="3078" id="token-27-6" morph="none" pos="punct" start_char="3078">,</TOKEN>
<TOKEN end_char="3082" id="token-27-7" morph="none" pos="word" start_char="3080">que</TOKEN>
<TOKEN end_char="3085" id="token-27-8" morph="none" pos="word" start_char="3084">se</TOKEN>
<TOKEN end_char="3094" id="token-27-9" morph="none" pos="word" start_char="3087">traducen</TOKEN>
<TOKEN end_char="3097" id="token-27-10" morph="none" pos="word" start_char="3096">en</TOKEN>
<TOKEN end_char="3103" id="token-27-11" morph="none" pos="word" start_char="3099">forma</TOKEN>
<TOKEN end_char="3111" id="token-27-12" morph="none" pos="word" start_char="3105">digital</TOKEN>
<TOKEN end_char="3116" id="token-27-13" morph="none" pos="word" start_char="3113">para</TOKEN>
<TOKEN end_char="3119" id="token-27-14" morph="none" pos="word" start_char="3118">su</TOKEN>
<TOKEN end_char="3123" id="token-27-15" morph="none" pos="word" start_char="3121">uso</TOKEN>
<TOKEN end_char="3126" id="token-27-16" morph="none" pos="word" start_char="3125">en</TOKEN>
<TOKEN end_char="3129" id="token-27-17" morph="none" pos="word" start_char="3128">la</TOKEN>
<TOKEN end_char="3134" id="token-27-18" morph="none" pos="word" start_char="3131">fase</TOKEN>
<TOKEN end_char="3144" id="token-27-19" morph="none" pos="word" start_char="3136">siguiente</TOKEN>
<TOKEN end_char="3145" id="token-27-20" morph="none" pos="punct" start_char="3145">.</TOKEN>
<TRANSLATED_TEXT>In addition, it receives several mutations weekly, which are translated into digital form for use in the next phase.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3311" id="segment-28" start_char="3148">
<ORIGINAL_TEXT>La segunda fase consiste en comparar la estructura digital de las proteínas del coronavirus con la biblioteca de moléculas disponible y encontrar las coincidencias.</ORIGINAL_TEXT>
<TOKEN end_char="3149" id="token-28-0" morph="none" pos="word" start_char="3148">La</TOKEN>
<TOKEN end_char="3157" id="token-28-1" morph="none" pos="word" start_char="3151">segunda</TOKEN>
<TOKEN end_char="3162" id="token-28-2" morph="none" pos="word" start_char="3159">fase</TOKEN>
<TOKEN end_char="3171" id="token-28-3" morph="none" pos="word" start_char="3164">consiste</TOKEN>
<TOKEN end_char="3174" id="token-28-4" morph="none" pos="word" start_char="3173">en</TOKEN>
<TOKEN end_char="3183" id="token-28-5" morph="none" pos="word" start_char="3176">comparar</TOKEN>
<TOKEN end_char="3186" id="token-28-6" morph="none" pos="word" start_char="3185">la</TOKEN>
<TOKEN end_char="3197" id="token-28-7" morph="none" pos="word" start_char="3188">estructura</TOKEN>
<TOKEN end_char="3205" id="token-28-8" morph="none" pos="word" start_char="3199">digital</TOKEN>
<TOKEN end_char="3208" id="token-28-9" morph="none" pos="word" start_char="3207">de</TOKEN>
<TOKEN end_char="3212" id="token-28-10" morph="none" pos="word" start_char="3210">las</TOKEN>
<TOKEN end_char="3222" id="token-28-11" morph="none" pos="word" start_char="3214">proteínas</TOKEN>
<TOKEN end_char="3226" id="token-28-12" morph="none" pos="word" start_char="3224">del</TOKEN>
<TOKEN end_char="3238" id="token-28-13" morph="none" pos="word" start_char="3228">coronavirus</TOKEN>
<TOKEN end_char="3242" id="token-28-14" morph="none" pos="word" start_char="3240">con</TOKEN>
<TOKEN end_char="3245" id="token-28-15" morph="none" pos="word" start_char="3244">la</TOKEN>
<TOKEN end_char="3256" id="token-28-16" morph="none" pos="word" start_char="3247">biblioteca</TOKEN>
<TOKEN end_char="3259" id="token-28-17" morph="none" pos="word" start_char="3258">de</TOKEN>
<TOKEN end_char="3269" id="token-28-18" morph="none" pos="word" start_char="3261">moléculas</TOKEN>
<TOKEN end_char="3280" id="token-28-19" morph="none" pos="word" start_char="3271">disponible</TOKEN>
<TOKEN end_char="3282" id="token-28-20" morph="none" pos="word" start_char="3282">y</TOKEN>
<TOKEN end_char="3292" id="token-28-21" morph="none" pos="word" start_char="3284">encontrar</TOKEN>
<TOKEN end_char="3296" id="token-28-22" morph="none" pos="word" start_char="3294">las</TOKEN>
<TOKEN end_char="3310" id="token-28-23" morph="none" pos="word" start_char="3298">coincidencias</TOKEN>
<TOKEN end_char="3311" id="token-28-24" morph="none" pos="punct" start_char="3311">.</TOKEN>
<TRANSLATED_TEXT>The second phase involves comparing the digital structure of coronavirus proteins with the available library of molecules and finding matches.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3481" id="segment-29" start_char="3313">
<ORIGINAL_TEXT>En la tercera y última fase, las moléculas identificadas se someten a varias operaciones de cribado biológico adicionales en laboratorios ubicados en Bélgica y Alemania.</ORIGINAL_TEXT>
<TOKEN end_char="3314" id="token-29-0" morph="none" pos="word" start_char="3313">En</TOKEN>
<TOKEN end_char="3317" id="token-29-1" morph="none" pos="word" start_char="3316">la</TOKEN>
<TOKEN end_char="3325" id="token-29-2" morph="none" pos="word" start_char="3319">tercera</TOKEN>
<TOKEN end_char="3327" id="token-29-3" morph="none" pos="word" start_char="3327">y</TOKEN>
<TOKEN end_char="3334" id="token-29-4" morph="none" pos="word" start_char="3329">última</TOKEN>
<TOKEN end_char="3339" id="token-29-5" morph="none" pos="word" start_char="3336">fase</TOKEN>
<TOKEN end_char="3340" id="token-29-6" morph="none" pos="punct" start_char="3340">,</TOKEN>
<TOKEN end_char="3344" id="token-29-7" morph="none" pos="word" start_char="3342">las</TOKEN>
<TOKEN end_char="3354" id="token-29-8" morph="none" pos="word" start_char="3346">moléculas</TOKEN>
<TOKEN end_char="3368" id="token-29-9" morph="none" pos="word" start_char="3356">identificadas</TOKEN>
<TOKEN end_char="3371" id="token-29-10" morph="none" pos="word" start_char="3370">se</TOKEN>
<TOKEN end_char="3379" id="token-29-11" morph="none" pos="word" start_char="3373">someten</TOKEN>
<TOKEN end_char="3381" id="token-29-12" morph="none" pos="word" start_char="3381">a</TOKEN>
<TOKEN end_char="3388" id="token-29-13" morph="none" pos="word" start_char="3383">varias</TOKEN>
<TOKEN end_char="3400" id="token-29-14" morph="none" pos="word" start_char="3390">operaciones</TOKEN>
<TOKEN end_char="3403" id="token-29-15" morph="none" pos="word" start_char="3402">de</TOKEN>
<TOKEN end_char="3411" id="token-29-16" morph="none" pos="word" start_char="3405">cribado</TOKEN>
<TOKEN end_char="3421" id="token-29-17" morph="none" pos="word" start_char="3413">biológico</TOKEN>
<TOKEN end_char="3433" id="token-29-18" morph="none" pos="word" start_char="3423">adicionales</TOKEN>
<TOKEN end_char="3436" id="token-29-19" morph="none" pos="word" start_char="3435">en</TOKEN>
<TOKEN end_char="3449" id="token-29-20" morph="none" pos="word" start_char="3438">laboratorios</TOKEN>
<TOKEN end_char="3458" id="token-29-21" morph="none" pos="word" start_char="3451">ubicados</TOKEN>
<TOKEN end_char="3461" id="token-29-22" morph="none" pos="word" start_char="3460">en</TOKEN>
<TOKEN end_char="3469" id="token-29-23" morph="none" pos="word" start_char="3463">Bélgica</TOKEN>
<TOKEN end_char="3471" id="token-29-24" morph="none" pos="word" start_char="3471">y</TOKEN>
<TOKEN end_char="3480" id="token-29-25" morph="none" pos="word" start_char="3473">Alemania</TOKEN>
<TOKEN end_char="3481" id="token-29-26" morph="none" pos="punct" start_char="3481">.</TOKEN>
<TRANSLATED_TEXT>In the third and final phase, the identified molecules undergo several additional biological screening operations in laboratories located in Belgium and Germany.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3623" id="segment-30" start_char="3483">
<ORIGINAL_TEXT>Así, comprenden cómo cada molécula identificada interactúa con el modelo del virus y para evaluar hasta qué grado puede detener su actividad.</ORIGINAL_TEXT>
<TOKEN end_char="3485" id="token-30-0" morph="none" pos="word" start_char="3483">Así</TOKEN>
<TOKEN end_char="3486" id="token-30-1" morph="none" pos="punct" start_char="3486">,</TOKEN>
<TOKEN end_char="3497" id="token-30-2" morph="none" pos="word" start_char="3488">comprenden</TOKEN>
<TOKEN end_char="3502" id="token-30-3" morph="none" pos="word" start_char="3499">cómo</TOKEN>
<TOKEN end_char="3507" id="token-30-4" morph="none" pos="word" start_char="3504">cada</TOKEN>
<TOKEN end_char="3516" id="token-30-5" morph="none" pos="word" start_char="3509">molécula</TOKEN>
<TOKEN end_char="3529" id="token-30-6" morph="none" pos="word" start_char="3518">identificada</TOKEN>
<TOKEN end_char="3540" id="token-30-7" morph="none" pos="word" start_char="3531">interactúa</TOKEN>
<TOKEN end_char="3544" id="token-30-8" morph="none" pos="word" start_char="3542">con</TOKEN>
<TOKEN end_char="3547" id="token-30-9" morph="none" pos="word" start_char="3546">el</TOKEN>
<TOKEN end_char="3554" id="token-30-10" morph="none" pos="word" start_char="3549">modelo</TOKEN>
<TOKEN end_char="3558" id="token-30-11" morph="none" pos="word" start_char="3556">del</TOKEN>
<TOKEN end_char="3564" id="token-30-12" morph="none" pos="word" start_char="3560">virus</TOKEN>
<TOKEN end_char="3566" id="token-30-13" morph="none" pos="word" start_char="3566">y</TOKEN>
<TOKEN end_char="3571" id="token-30-14" morph="none" pos="word" start_char="3568">para</TOKEN>
<TOKEN end_char="3579" id="token-30-15" morph="none" pos="word" start_char="3573">evaluar</TOKEN>
<TOKEN end_char="3585" id="token-30-16" morph="none" pos="word" start_char="3581">hasta</TOKEN>
<TOKEN end_char="3589" id="token-30-17" morph="none" pos="word" start_char="3587">qué</TOKEN>
<TOKEN end_char="3595" id="token-30-18" morph="none" pos="word" start_char="3591">grado</TOKEN>
<TOKEN end_char="3601" id="token-30-19" morph="none" pos="word" start_char="3597">puede</TOKEN>
<TOKEN end_char="3609" id="token-30-20" morph="none" pos="word" start_char="3603">detener</TOKEN>
<TOKEN end_char="3612" id="token-30-21" morph="none" pos="word" start_char="3611">su</TOKEN>
<TOKEN end_char="3622" id="token-30-22" morph="none" pos="word" start_char="3614">actividad</TOKEN>
<TOKEN end_char="3623" id="token-30-23" morph="none" pos="punct" start_char="3623">.</TOKEN>
<TRANSLATED_TEXT>Thus, they understand how each identified molecule interacts with the virus model and to assess to what extent it can stop its activity.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3650" id="segment-31" start_char="3626">
<ORIGINAL_TEXT>Noticias complementarias:</ORIGINAL_TEXT>
<TOKEN end_char="3633" id="token-31-0" morph="none" pos="word" start_char="3626">Noticias</TOKEN>
<TOKEN end_char="3649" id="token-31-1" morph="none" pos="word" start_char="3635">complementarias</TOKEN>
<TOKEN end_char="3650" id="token-31-2" morph="none" pos="punct" start_char="3650">:</TOKEN>
<TRANSLATED_TEXT>Additional news:</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>